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Abstract
Probing gene function in the mammalian brain can be greatly assisted with methods to manipulate 
the genome of neurons in vivo. The clustered, regularly interspaced, short palindromic repeats 
(CRISPR)-associated endonuclease (Cas)9 from Streptococcus pyogenes (SpCas9)1 can be used to 
edit single or multiple genes in replicating eukaryotic cells, resulting in frame-shifting insertion/
deletion (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and guide 
RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as well as multiple 
genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in vivo. We characterized the effects 
of genome modifications in postmitotic neurons using biochemical, genetic, electrophysiological 
and behavioral readouts. Our results demonstrate that AAV-mediated SpCas9 genome editing can 
enable reverse genetic studies of gene function in the brain.
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The SpCas9 nuclease can be reprogrammed to target specific genomic loci in mammalian 
cells using single guide RNAs (sgRNAs) and has been used in a variety of genome editing 
applications1. Recently, SpCas9 has been applied in mice using hydrodynamic injection2,3 
and adenovirus delivery4 in the liver. To enable SpCas9 use for editing cells in the 
mammalian nervous system in vivo, we sought to adapt a set of AAV vectors that are 
commonly used for brain gene delivery. Because of the packaging size limitation of AAV 
vectors5, we designed a dual-vector system that packages SpCas9 (AAV-SpCas9) and 
sgRNA expression cassettes (AAV-SpGuide) in two separate viral vectors (Fig. 1a).
We assessed various, short, neuron-specific promoters as well as polyadenylation signals to 
achieve efficient packaging of SpCas9 in AAV vectors. For our final design we chose a 
truncated version of the mouse Mecp2 promoter (235 bp, pMecp2) and a minimal 
polyadenylation signal (48 bp, spA)6. To identify SpCas9-expressing neurons, we tagged 
SpCas9 with an HA-epitope tag (Supplementary Fig. 1). For the AAV-SpGuide vector, we 
packaged a U6-sgRNA expression cassette together with the green fluorescent protein (GFP) 
fused to the KASH nuclear transmembrane domain7 driven by the human Synapsin I 
promoter (Fig. 1a). The KASH domain directs the fused GFP protein to the outer nuclear 
membrane and enables identification of neurons transduced by AAV-SpGuide 
(Supplementary Fig. 2a,b).
To test the delivery efficacy of our dual-vector system, we first transduced primary mouse 
cortical neurons in vitro. We observed robust expression of AAV-SpCas9 and AAV-
SpGuide, with a co-transduction efficiency of ~75% (Supplementary Fig. 2b,c). AAV-
mediated expression of SpCas9 did not adversely affect the morphology and survival of 
transduced neurons (Supplementary Figs. 1c and 2b,d).
We next sought to test SpCas9-mediated genome editing in mouse primary neurons. First we 
targeted an X-chromosomal gene, Mecp2 (methyl CpG binding protein), which plays an 
important role in the pathogenesis of Rett syndrome8. MeCP2 is ubiquitously expressed in 
neurons throughout the brain, and its deficiency has been shown to be associated with severe 
morphological and electrophysiological phenotypes in neurons as well as misregulation of 
gene expression, all of which are thought to contribute to the neurological symptoms of Rett 
syndrome9-11. We designed several sgRNAs targeting exon 3 of the mouse Mecp2 gene and 
evaluated their effectiveness in indel generation in the Neuro-2a cells. The most efficient 
sgRNA (Mecp2 target 5, Supplementary Fig. 3) was used in subsequent in vitro and in vivo 
Mecp2 targeting experiments.
To assess the editing efficiency of our dual-vector system, we transduced mouse primary 
cortical neurons with SpCas9 and Mecp2-targeting sgRNA or control sgRNA (targeting the 
bacterial lacZ gene). Using immunocytochemistry we observed that >70% of cells 
transduced with Mecp2-targeting sgRNA were MeCP2-negative 7 d post-transduction 
(Supplementary Fig. 4a,b). We also confirmed a corresponding decrease in MeCP2 protein 
levels using western blot analysis (Supplementary Fig. 4c). Binding by the catalytically 
inactive SpCas9 (D10A/H840A, dSpCas9) may repress gene expression by blocking 
transcription12-14. To test that possibility, we co-expressed dSpCas9 and Mecp2-targeting 
sgRNA in neurons. We did not observe any reduction in protein levels (Supplementary Fig. 
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4a–c), suggesting that MeCP2 knockdown is likely due to indels in the Mecp2 locus 
(Supplementary Fig. 4d). To assess efficiency of Mecp2 modification in targeted cells, we 
purified GFP-KASH+ nuclei using fluorescence-activated cell sorting (FACS) 
(Supplementary Fig. 4e,f) and sequenced the Mecp2 locus using targeted next-generation 
sequencing (NGS). We found that ~65% of the GFP-KASH+ nuclei (n = 103) were 
genetically modified within the Mecp2 locus. MeCP2 loss-of-function can lead to dendritic 
tree abnormalities and spine morphogenesis defects in neurons10,11. Therefore, we 
investigated whether SpCas9-mediated MeCP2 depletion in cultured neurons could 
recapitulate these morphological phenotypes. Neurons co-expressing SpCas9 and Mecp2-
targeting sgRNA exhibited altered dendritic tree morphology and spine density when 
compared with control neurons (lacZ-targeting sgRNA) (Supplementary Fig. 5).
Efficient editing of neuronal genes in vivo would enable direct testing of gene function in 
relevant cell types embedded in their native contexts. Therefore, we tested whether 
CRISPR-Cas9 could mediate stable genomic modifications in neurons in the brains of living 
mice. We stereotactically injected a mixture (1:1 ratio) of AAV-SpCas9 and AAV-SpGuide 
(Mecp2- or lacZ-targeting sgRNAs) into the hippocampal dentate gyrus (DG) of adult male 
mice. We observed ~80% co-transduction efficiency of both vectors (GFP-KASH+/HA-
Cas9+ cells by means of co-staining) in hippocampal granule cells at 4 weeks after viral 
injection (Supplementary Fig. 6).
Isolation of subsets of cells from heterogeneous brain tissue for downstream analysis can be 
achieved by fluorescent labeling of cells followed by FACS. However, due to the complex 
morphology of neurons, dissociation of individual cells from adult brain tissue is a major 
impediment to subsequent analyses15. Therefore, we established a protocol to purify intact 
nuclei of transduced cells from dissected brain tissue (Fig. 1b). Using NGS, we quantified 
indel formation in the targeted Mecp2 locus at the single-cell level and found that ~68% of 
targeted cells contained indel mutations 2 weeks after viral delivery (Fig. 1c,d). The number 
of MeCP2-positive nuclei in the DG was decreased by ~70% in the DG of animals injected 
with AAV-SpCas9 and Mecp2-targeting sgRNA. Total MeCP2 protein levels were also 
decreased by >60% (Fig. 1e–g). These results demonstrate the efficiency of AAV-mediated 
genome editing in the adult brain and suggest that SpCas9 can be used to directly perturb 
specific genes within intact biological contexts.
MeCP2 has a fundamental role in learning, which can be measured by the contextual fear-
conditioning paradigm (CFC)16. The dorsal DG region is the structure crucial for contextual 
learning17. Given the efficient depletion of MeCP2 in the DG we investigated the behavioral 
consequences of Mecp2 gene editing. CFC behavioral tests revealed that CRISPR-Cas9–
mediated inactivation of MeCP2 in the DG impaired contextual memory (Fig. 1h), similar to 
what was previously observed in MeCP2 mutant mice16. No difference was observed when 
mice were tested in an altered context, suggesting contextual specificity of the memory 
trace. In contrast, Mecp2 knockdown mice did not exhibit any altered behavior in open field 
testing, novel object recognition or the elevated plus maze. These data suggest that the 
MeCP2 depletion in the dorsal DG affects contextual learning but leaves other cognitive 
abilities intact (Supplementary Fig. 7).
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In vivo genome editing in neurons may also be used to study cellular processes, such as 
transcription dynamics. Depletion of MeCP2 is known to result in genome-wide 
transcriptional dysregulation18, which may contribute to learning deficits. To test the effect 
of MeCP2 knockdown on the transcription state of adult neurons in the DG, we sequenced 
mRNA from FACS-purified GFP-KASH+ nuclei from dissected DG tissue (Fig. 1b and 
Supplementary Fig. 8). Out of 556 highly expressed genes, we found 34 differentially 
expressed between neurons receiving Mecp2- and lacZ-targeting sgRNAs (Fig. 2 and 
Supplementary Fig. 9). These results show that the combination of SpCas9-mediated 
genome perturbation, intact nuclei purification and RNA-seq analysis provides a robust 
method to study transcriptional regulation in adult neurons in vivo and identify candidate 
genes that might modulate specific neuronal functions or disease processes.
We next analyzed the effect of genomic perturbation of Mecp2 on the physiological 
properties of targeted cells in intact brain circuits. Primary visual cortex (V1) has long been 
a model for deciphering mechanisms underlying integrative responses of cortical neurons, 
including orientation selectivity, a crucial response feature created within V1 (ref. 19). The 
effects of MeCP2 on cortical circuits that create such responses are unresolved20. We 
stereotactically injected AAV-SpCas9 and AAV-SpGuide targeting Mecp2 into the 
superficial layers of V1 (Fig. 3a). Two weeks later, we performed in vivo two- photon-
guided cell-attached recordings in anesthetized mice (Fig. 3b,c) to compare the 
electrophysiological responses of excitatory GFP-KASH+ neurons with neighboring control 
neurons expressing GFP-KASH and lacZ gRNA, respectively. V1 neurons are selectively 
tuned to respond to a specific orientation of a visual stimulus, a parameter that can be 
measured as orientation selectivity index (OSI). Responses to a full range of oriented 
drifting gratings (Fig. 3d,e) showed that the OSI was reduced in GFP-KASH+ neurons 
targeted with Mecp2 sgRNA (Fig. 3f), along with peak responses at the optimal orientation 
(Fig. 3g) when compared to lacZ sgRNA expressing-control neurons. Previous studies have 
reported decreased synaptic drive to pyramidal neurons in hippocampal slices of germline 
Mecp2 knockout mice21 and after short hairpin RNA-mediated knockdown of MeCP2 in 
mouse motor cortex22. These experiments confirm that alterations in visual drive and tuning 
occur in genome-edited neurons in functional circuits. Cas9-mediated MeCP2 depletion in 
adult mice underscores the maintenance role of MeCP2 in adult brain23 and reveals the role 
of MeCP2 in the integration of inputs that underlie a cortical response feature; it further 
demonstrates the versatility of SpCas9 in facilitating targeted gene knockdown in the 
mammalian brain in vivo for studying gene function in health and disease.
Many cellular processes affecting physiological and neuropathological conditions are 
controlled by groups of genes, some of which have compensatory roles. Therefore, targeting 
only one gene in a network may not provide sufficient perturbation for the biological 
process of interest. To test whether SpCas9 could be used for multiplex genome editing in 
the brain, we designed an expression vector with three U6-sgRNA cassettes in tandem, 
along with GFP-KASH for nuclei labeling (Fig. 4a). We chose sgRNAs targeting the family 
of DNA methyltransferases (DNMTs: Dnmt1, Dnmt3a and Dnmt3b). Dnmt1 and Dnmt3a 
are highly expressed in the adult brain and are required for synaptic plasticity, learning and 
memory formation24. As Dnmt1 and Dnmt3a were shown to be mutually redundant in these 
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cognitive processes24, they are good targets for testing multiplex gene editing. To avoid any 
potential compensatory effects by Dnmt3b, we also targeted this gene even though it is 
mainly expressed during neurodevelopment24. We selected individual sgRNAs for 
simultaneous targeting of DNMTs genes by testing their efficiencies using the Neuro-2a cell 
line (Fig. 4b and Supplementary Fig. 10).
To test the efficacy of multiplex genome editing in vivo, we stereo-tactically injected a 
mixture of AAV-SpCas9 and AAV-SpGuide (targeting Dnmt3a, Dnmt1 and Dnmt3b) into 
the DG of adult mice. After 8 weeks, individual nuclei from transduced cells were analyzed 
with NGS. We detected indels in all three loci with ~75% modification rate in Dnmt1 and 
Dnmt3a, and ~50% in Dnmt3b (Fig. 4c and Supplementary Fig. 11).
Recent studies with SpCas9 have shown that when genomic loci partially match the sgRNA, 
the result can be off-target indel formation25,26. We computationally identified highly 
similar genomic target sites26 and quantified the rate of modifications using NGS. Indel 
analysis of the top predicted off-target loci in sorted nuclei from transduced brain tissue 
(AAV-SpCas9 and AAV-SpGuide targeting Dnmt1, Dnmt3a and Dnmt3b) revealed a 0–
1.6% indel formation, suggesting that SpCas9 did not cause pervasive off-target mutagenesis 
in these animals (Supplementary Table 1).
Although previous in vivo studies using SpCas9 analyzed population- averaged indel 
frequency2,3, two important questions remain open, namely, how efficiently are both alleles 
of targeted genes modified, and what is the effectiveness of simultaneous targeting of 
multiple loci in single cells? We first examined, using targeted sequencing of single nuclei, 
the frequency of cells in which both alleles of Dnmt were disrupted. Our results show 
biallelic modification of Dnmt1 in >60% of transduced cells, and 42% and 17% of 
transduced cells for Dnmt3a and Dnmt3b, respectively (Fig. 4c). Observed differences in 
indel formation between different loci may be due to variations in the chromatin state and 
accessibility of target sites. Next, we quantified multiplex targeting efficiency at each Dnmt 
locus (Fig. 4d). Approximately 62% of all transduced neurons contained indels in both 
Dnmt1 and Dnmt3a, whereas simultaneous modification of Dnmt1, Dnmt3a and Dnmt3b 
was found in ~35% of all transduced neurons. These results are consistent with Dnmt3a and 
Dnmt1 protein depletion levels in the DG (Fig. 4e). Because of the low expression levels of 
Dnmt3b in the adult brain, we were not able to detect Dnmt3b protein using western blot 
analysis.
Dnmt3a and Dnmt1 knockout mice have previously been reported to show altered 
hippocampal-dependent memory formation24. Owing to potentially compensatory functions, 
both genes need to be depleted for learning deficits to be observed. We therefore performed 
CFC behavior tests to investigate the effect of SpCas9-mediated knockdown of DNMTs on 
memory acquisition and consolidation. Triple DNMT knockdown mice showed impaired 
memory formation when tested under trained context conditions (Fig. 4f). However, no 
phenotype was observed in the open field, elevated plus maze and novel object recognition 
tests (Supplementary Fig. 12). In contrast to classical mouse models, which feature complete 
gene knockout, AAV-SpCas9 mediated knockdown may only provide perturbation in a 
fraction of targeted cells. Therefore, applications of the current AAV-SpCas9 system in 
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complex tissues should be carefully designed and may be most effective for studying the 
effect of loss-of-function mutations on cell-autonomous properties.
AAV-mediated in vivo delivery of SpCas9 and sgRNA provides a rapid and powerful 
technology for precise genomic perturbations in vivo. We show that SpCas9 can be used to 
edit the genome of post-mitotic neurons in adult mice with high efficiency. SpCas9-
mediated genomic perturbations can be readily combined with biochemical, sequencing, 
electrophysiological and behavioral analyses to study the function of the targeted genomic 
elements. SpCas9-mediated targeting of single or multiple genes can induce phenotypes 
similar to those previously observed in classic genetic mouse models. The use of SpCas9 not 
only necessitates the use of two AAV vectors, but also limits the size of promoter elements 
that can be used to achieve cell type–specific targeting. Given the diversity of Cas9 
orthologs, some of which are substantially shorter than SpCas9 (refs. 27-29), it may be 
possible to engineer single AAV vectors that express both Cas9 and sgRNA, or Cas9 can be 
integrated to the genome to reduce the delivery burden30. Cas9 may also be combined with 
Cre-Lox systems to restrict Cas9-mediated genome editing to specific neuronal subtypes or 
circuit elements, thereby enhancing the ability of the CRISPR-Cas9 technology to dissect 
gene functions in brain processes.
ONLINE METHODS
Animals
The MIT Committee on Animal Care (CAC) approved all animal procedures described here. 
Adult (12-26 weeks old) male C57BL/6N mice were used in the study.
DNA constructs
For SpCas9 targets selection and generation of single guide RNA (sgRNA), the 20-nt target 
sequences were selected to precede a 5′-NGG protospacer-adjacent motif (PAM) sequence. 
To minimize off-targeting effects, the CRISPR design tool was used (http://crispr.mit.edu/). 
sgRNA was PCR amplified using U6 promoter as a template with forward primer: 5′-
CGCACGCGTAATTCGAACGCTGACGTCATC-3′ and reverse primer containing the 
sgRNA with 20-nt DNA target site (bold): 5′-
CACACGCGTAAAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGAC
TAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACNNNNNNNNNNNNNNNNN
NNCGGTGTTTCGTCCTTTCCAC-3′. Control sgRNA sequence was designed to target 
lacZ gene from Escherichia coli (target sequence: TGCGAATACGCCCACGCGATGGG). 
EGFP-KASH7 construct was a generous gift from Prof. Worman (Columbia University, 
NYC) and was used as PCR template for cloning the coding cassette into AAV backbone 
under the human Synapsin promoter (hSyn). U6-Mecp2sgRNA coding sequence was 
introduced using Mlu I site. For the multiplex gene targeting strategy, individual sgRNAs 
were PCR amplified as described above. All three sgRNAs were ligated with PCR amplified 
hSyn-GFP-KASH-bGHpA cassette (Fig. 4a) by using the Golden Gate cloning strategy. 
After PCR amplification, the ligation product containing three sgRNAs and hSyn-GFP-
KASH-bGH pA was cloned into AAV backbone. All obtained constructs were sequenced 
verified. In order to find the optimal promoter sequence to drive SpCas9 expression in 
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neurons we tested: hSyn1, mouse truncated Mecp2 (pMecp2), and truncated rat Map1b 
(pMap1b) promoter sequences6 (Supplementary Fig. 1a). The following primers were used 
to amplify promoter regions: hSyn_F: 5′-GTGTCTAGACTGCAGAGGGCCCTG-3′; 
hSyn_R: 5′-GTGTCGTGCCTGAGAGCGCAGTCGAGAA-3′; Mecp2_F 5′-
GAGAAGCTTAGCTGAATGGGGTCCGCCTC-3′; Mecp2_R 5′-
CTCACCGGTGCGCGCAACCGATGCCGGGACC-3′; Map1b-283/-58_F 5′-
GAGAAGCTTGGCGAAATGATTTGCTGCAGATG-3′; Map1b-283/-58_R 5′-
CTCACCGGTGCGCGCGTCGCCTCCCCCTCCGC-3′.
Another truncation of rat map1b promoter was assembled with the following oligos: 5′-
AGCTTCGCGCCGGGAGGAGGGGGGACGCAGTGGGCGGAGCGGAGACAGCACCT
T 
CGGAGATAATCCTTTCTCCTGCCGCAGAGCAGAGGAGCGGCGGGAGAGGAACA
CTT CTCCCAGGCTTTAGC AGAGCCGGA-3′ and 5′-
CCGGTCCGGCTCTGCTAAAGCCTGGGAGAAGTGTTCCTCTCCCGCCGCTCCTCTG
CTCTGCGGCAGGAGAAAGGATTATCTCCGAAGGTGCTGTCTCCGCTCCGCCCAC
TGCGTCCCCCCTCCTCCCGGCGCGA-3′. Short synthetic polyadenylation signal (spA)31 
was assembled using the following DNA oligonucleotides: 5′-
AATTCAATAAAAGATCTTTATTTTCATTAGATCTGTGTGTTGGTTTTTTGTGTGC-
3′ and 5′- 
GGCCGCACACAAAAAACCAACACACAGATCTAATGAAAATAAAGATCTTTTATT
G-3′. SpCas9 and its D10A/H840A mutant version (dSpCas9) were described 
previously27,32,33. Plasmid encoding red fluorescent protein (mCherry) under control of 
EF1α promoter was used for neuron transfection with Lipofectamine 2000 (Life 
Technologies).
Cell line cultures and transfection
Neuro-2a (N2a) cells were grown in DMEM containing 5% FBS (BSA). For HEK293FT 
cells DMEM containing 10% FBS (FBS) was used. Cells were maintained at 37 °C in 5% 
CO2 atmosphere. Cells were transfected using Lipofectamine 2000 or Polyethylenimine 
(PEI) “MAX” reagent (Polysciences), according to manufacturer’s protocols.
Production of concentrated AAV vectors
High titer AAV1/2 particles were produced using AAV1 and AAV2 serotype plasmids at 
equal ratios and pDF6 helper plasmid in HEK293FT and purified on heparin affinity 
column34. Titering of viral particles was done with qPCR. High titer AAV1 particles were 
produced by the UNC Vector Core Services (University of North Carolina at Chapel Hill). 
Low titer AAV1 particles in DMEM were produced as described previously35. Briefly, 
HEK293FT cells were transfected with transgene plasmid, pAAV1 serotype plasmid and 
pDF6 helper plasmid using PEI “MAX”. Culture medium was collected after 48 h and 
filtered through a 0.45 μm PVDF filter (Millipore).
Primary cortical neuron culture
Primary cultures were prepared from embryonic day 16 mouse brains36. Embryos of either 
sex were used. Cells were plated on poly-D-lysine (PDL)-coated 24-well plates (BD 
Swiech et al. Page 7
Nat Biotechnol. Author manuscript; available in PMC 2015 July 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Biosciences) or laminin/PDL-coated coverslips (VWR). Cultures were grown at 37 °C and 
5% CO2 in Neurobasal medium, supplemented with B27, Glutamax (Life Technologies) and 
penicillin/streptomycin mix.
For AAV transduction, cortical neurons in 500 μl Neurobasal culture medium were 
incubated at 7 DIV with up to 300 μl (double infection at 1:1 ratio) AAV1-containing 
conditioned medium from HEK293FT cells35. One week after transduction neurons have 
been harvested for downstream processing or fixed in 4% paraformaldehyde for 
immunofluorescent stainings or morphology analysis.
For visualization of neuronal morphology, cells at DIV7 were transfected with EF1α-
mCherry expression vector using Lipofectamine 2000 (Life Technologies) for 1 week as 
previously described37. For measurement of total dendrite length, all dendrites of individual 
neurons were traced using ImageJ software. Quantification of the number of primary 
dendrites, dendritic tips and the Sholl analysis38 were performed on images acquired with 
fluorescent microscope at a 40× objective (Zeiss AxioCam A×10 microscope, Axiocam 
MRm camera). For dendrites number, ends of all non-axonal protrusions longer than 10 μm 
were counted. For Sholl analysis, concentric circles with 5 μm step in diameter were 
automatically drawn around the cell body, and the number of dendrites crossing each circle 
was counted using ImageJ software with a Sholl plug-in.
Cell culture preparation and purification of cell nuclei
7 days after viral delivery, cells were harvested in 200 μl ice-cold PBS and cell pellets were 
spun down at 2,000g for 10 min at 4 °C. Cell pellets were swelled on ice for 5 min in 1 ml 
lysis buffer (10 mM β-glycerophosphate (pH 7.0), 2 mM MgCl2, 1 mM PMSF, 1 mM β-
mercaptoethanol, 1% Tween-20). 1 ml ddH2O was added and lysate was kept on ice for 5 
min before cell lysates were homogenized with Dounce homogenizer (Sigma); 20 times with 
pestle A, followed by 10 times with pestle B. 2 ml equilibration buffer (120 mM β-
glycerophosphate pH 7.0, 2 mM MgCl2, 1 mM PMSF, 1 mM β-mercaptoethanol, 50% 
glycerol) was added and nuclei were centrifuged (1,000g for 10 min at 4 °C) using a sucrose 
gradient (lower: 500 mM sucrose, 2 mM MgCl2, 25 mM KCl, 65 mM β-glycerophosphate 
pH 7.0, 20% glycerol, 1 mM PMSF, 1 mM β-mercaptoethanol; upper: 340 mM sucrose, 2 
mM MgCl2, 25 mM KCl, 65 mM β-glycerophosphate (pH 7.0), 20% glycerol, 1 mM PMSF, 
1 mM β-mercaptoethanol). Number and quality of purified nuclei was controlled using 
bright-field microscopy.
Stereotactic injection of AAV1/2 into the mouse brain
Mice were anesthetized by intraperitoneal (i.p.) injection of 100 mg/kg ketamine and 10 
mg/kg xylazine. Preemptive analgesia was given (Buprenex, 1 mg/kg, i.p.). Craniotomy was 
performed according to approved procedures, and 1 μl of 1:1 AAV mixture (1 × 1013 vector 
genomes (Vg)/ml) of sMecp2-SpCas9; 6 × 1012 Vg/ml of DNMT 3×sgRNA; 3–5 × 1012 
Vg/ml of hSyn-GFP-KASH) was injected into: dorsal dentate gyrus (anterior/posterior: −1.7; 
mediolateral: 0.6; dorsal/ventral: −2.15) and/or ventral dentate gyrus (anterior/posterior: 
−3.52; mediolateral: 2.65; dorsal/ventral: −3). For in vivo electrophysiology recording 
experiments (Fig. 4), virus injection coordinates were 3 mm lateral (from Bregma) and 1 
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mm anterior from the posterior suture. The skull was thinned using a dremel drill with 
occasional cooling with saline, and the remaining dura was punctured using a glass 
micropipette filled with the virus suspended in mineral oil. Several injections (3–4) were 
made at neighboring sites, at a depth of 200–250 μm. A volume of 150–200 nl of virus 
mixture was injected at 75 nl/min rate at each site. After each injection, the pipette was held 
in place for 3-5 min before retraction to prevent leakage. The incision was sutured and 
proper post-operative analgesics (Meloxicam, 1–2 mg/kg) were administered for 3 d 
following surgery.
In vivo two-photon guided targeted loose patch recordings
Two weeks after virus injection, mice were used for electrophysiology experiments. Mice 
were anesthetized with 2% isoflurane and maintained using 0.8% isoflurane. The skin was 
excised, cleaned with sugi and a metal head plate was attached to the skull using glue and 
dental acrylic, and a 2 × 2 mm craniotomy was performed over the primary visual cortex 
(V1). The exposed area was then covered with a thin layer of 1.5% agarose in artificial 
cerebrospinal fluid (aCSF; 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 0.01 mM 
EDTA, 10 mM HEPES, 10 mM glucose; pH 7.4). Animal body temperature was maintained 
during experiment 37.5 °C with a heating blanket.
Borosilicate pipettes (WPI) were pulled using a Sutter P-2000 laser puller (Sutter 
Instruments). Tip diameter was around 1 μm while the resistance was between 3–5 MΩ. 
Recordings were made using custom software (Network Prism, Sur lab), written in Matlab 
(MathWorks), controlling a MultiClamp 700B amplifier (Axon). A glass pipette electrode 
was inserted into the brain at an angle of 20–35 degrees and an Ag/AgCl ground electrode 
pellet (Warner Instruments) was positioned in the same solution as the brain and the 
objective. For fluorescent visualization, pipettes were filled with Alexa Fluor 594 
(Molecular Probes). The pipette was first targeted to the injection site using a 10× lens, and 
then targeted to individual GFP+ cells using a 25× lens via simultaneous two-photon 
imaging at 770 nm. Cell proximity was detected through deflections in resistance observed 
in voltage clamp during a rapidly time-varying 5 mV command voltage pulse. Once 
resistance had increased by 5–10 MΩ, the amplifier was switched to current clamp, and 
spikes were recorded with zero injected current, under a Bessel filter of 4 KHz and an AC 
filter of 300 Hz. Virus-injected brains were perfused post hoc and immunohistochemistry 
was performed.
Visual stimulation and data analysis from in vivo two-photon–guided targeted loose patch 
recordings
Oriented gratings using custom software written in Matlab PsychToolbox-3 were presented 
to assess the orientation selectivity and tuning of genome-edited neurons. Gratings were 
optimized for cellular responsiveness and were presented by stepping the orientation from 
0–360 degrees in steps of 20 degrees, with each grating presentation being preceded for 4 s 
“off ” followed by 4 s “on,” for a total presentation duration of 144 s. Data were acquired 
directly into Matlab. Spike detection was performed via analysis routines that used manually 
defined thresholds followed by spike shape template matching for further verification. Every 
spike was tagged and displayed on screen in a graphical user interface whereupon it was 
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manually reviewed for false positives and negatives by the experimenter. Spike times in 
response to every stimulus were then grouped into “on” or “off ” periods based on their 
timing relative to visual stimulation, and “on” spikes for each stimulus were decremented by 
the number of “off” spikes observed during an equal time period. For orientation 
experiments, # spikes per stimulus = (# spikes “on”) − (# spikes “off ”) because “on” and 
“off ” periods were the same duration.
For every cell of interest, the methods were used to collect responses for each oriented 
stimulus (0 to 360 degrees, in steps of 20 degrees). These responses were then turned into a 
“tuning curve” of orientation versus response for each trial. Orientation Selectivity Index 
(OSI) was computed by taking the vector average for the preferred orientation:
Tissue preparation and purification of cell nuclei
Total hippocampus of adult male mice was quickly dissected in ice cold DPBS (Life 
Sciences). Dentate gyrus (DG) samples were prepared and separated from Ammon’s horn 
(CA) as described elsewhere39. Samples were directly used for downstream analysis or 
shock frozen on dry ice. For cell nuclei purification, dissected tissue was gently 
homogenized in 2 ml ice-cold homogenization buffer (HB) (320 mM sucrose, 5 mM CaCl, 3 
mM Mg(Ac)2, 10 mM Tris pH7.8, 0.1 mM EDTA, 0.1% NP40, 0.1 mM PMSF, 1 mM β-
mercaptoethanol) using 2 ml Dounce homogenizer (Sigma); 25 times with pestle A, 
followed by 25 times with pestle B. Next, 3 ml of HB was added up to 5 ml total and kept on 
ice for 5 min. For gradient centrifugation, 5 ml of 50% OptiPrep density gradient medium 
(Sigma) containing 5 mM CaCl, 3 mM Mg(Ac)2, 10 mM Tris pH 7.8, 0.1 mM PMSF, 1 mM 
β-mercaptoethanol was added and mixed. The lysate was gently loaded on the top of 10 ml 
29% iso-osmolar OptiPrep solution in a conical 30 ml centrifuge tube (Beckman Coulter, 
SW28 rotor). Samples were centrifuged at 10,100 × g (7,500 r.p.m.) for 30 min at 4 °C. The 
supernatant was removed and the nuclei pellet was gently resuspended in 65 mM β-
glycerophosphate (pH 7.0), 2 mM MgCl2, 25 mM KCl, 340 mM sucrose and 5% glycerol. 
Number and quality of purified nuclei was controlled using bright-field microscopy.
Cell nuclei sorting
Purified KASH-GFP-positive (GFP+) and negative (GFP−) intact nuclei were co-labeled 
with Vybrant DyeCycle Ruby Stain (1:500, Life Technologies) and sorted using BD 
FACSAria III (Koch Institute Flow Cytometry Core, MIT). After sorting, all samples were 
kept on ice and centrifuged at 10,000g for 20 min at 4 °C. Nuclei pellets were stored at −80 
°C or were directly used for downstream processing. Single-cell nuclei were sorted using 
Beckman Coulter MoFlo Astrios EQ Cell Sorter (FACS Center for Systems Biology, 
Harvard University) in 5 μl of QuickExtract DNA Extraction Kit (Epicentre) in 96-well 
format.
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Genomic DNA extraction and SURVEYOR assay
For functional testing of sgRNA, 50–70% confluent N2a cells were co-transfected with a 
single PCR amplified sgRNA and SpCas9 vector. Cells transfected with SpCas9 only served 
as negative control. Cells were harvested 48 h after transfection, and DNA was extracted 
using DNeasy Blood & Tissue Kit (Qiagen) according to the manufacturer’s protocol. To 
isolate genomic DNA from AAV1 transduced primary neurons, DNeasy Blood & Tissue Kit 
was used 7 d after AAV transduction, according to the manufacturer’s instruction.
Sorted nuclei of dissected tissues were lysed in lysis buffer (10 mM Tris, pH 8.0, 10 mM 
NaCl, 10 mM EDTA, 0.5 mM SDS, 1 μg/μl of proteinase K and 50 ng/μl RNase A) at 55 °C 
for 30 min. Next, chloroform-phenol extraction was performed followed by DNA 
precipitation with ethanol, according to standard procedures. DNA was finally resuspended 
in TE Buffer (10 mM Tris pH 8.0, 0.1 mM EDTA) and used for downstream analysis. 
Functional testing of individual sgRNAs was performed with SURVEYOR nuclease assay 
(Transgenomics) using PCR primers listed in Supplementary Table 2. Band intensity 
quantification was performed as described before40. For next-generation sequencing, DNA 
of single-cell nuclei was extracted in QuickExtract DNA Extraction Kit (Epicentre) 
according to the manufacturer’s protocol.
RNA library preparation and sequencing
Two weeks after bilateral viral delivery of SpCas9 with guide targeting Mecp2 (four 
animals) or SpCas9 with gRNA targeting lacZ (four animals), DG and CA1 regions of 
hippocampus were quickly dissected in ice cold DPBS (Life Sciences) as previously 
described39 and transferred immediately to RNA-later solution (Ambion). After 24 h in 4 °C 
the tissue was moved to −80 °C. Populations of 100 targeted neuronal nuclei were FACS 
sorted into 10 μl of TCL buffer supplemented with 1% 2-mercaptoethanol (Qiagen), 
centrifuged for 1 min and then frozen immediately on dry ice. RNA was purified by 
AMPure RNAcleanXP SPRI beads (Beckman Coulter Genomics) following the 
manufacturer’s instructions, and washed three times with 80% ethanol, omitting the final 
elution. The beads with captured RNA were air-dried and processed immediately for cDNA 
synthesis. Samples with no nuclei were used as negative controls. Three DG population 
samples were used from each animal, to a total of 24 population samples, and an additional 
6 population samples taken from the CA1 region of control animals. From each sample a 
cDNA library was prepared following the SMART-seq2 protocol as previously done41, only 
replacing the reverse transcriptase enzyme with 0.1 μl of Maxima H Minus enzyme (200 
U/μl, Thermo Scientific), and scaling down the PCR reaction to a volume of 25 μl. The 
tagmentation reaction and final PCR amplification were done using the Nextera XT DNA 
Sample preparation kit (Illumina), with the following modifications: all reaction volumes 
were scaled down by a factor of 4, and the libraries were pooled after the PCR amplification 
step by taking 2.5 μl of each sample. The pooled libraries were cleaned and size-selected 
using two rounds of 0.7 volume of AMPure XP SPRI bead cleanup (Beckman Coulter 
Genomics). Samples were loaded on a High-Sensitivity DNA chip (Agilent) to check the 
quality of the library, whereas quantification was done with Qubit High-Sensitivity DNA kit 
(Invitrogen). The pooled libraries were diluted to a final concentration of 4 nM and 12 pmol 
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and were sequenced using the Illumina MiSeq Personal Sequencer (Life Technologies) with 
75 bp paired end reads.
RNA libraries data analysis
Bowtie2 index was created based on the mouse mm9 UCSC genome and known Gene 
transcriptome42, and paired-end reads were aligned directly to this index using Bowtie2 with 
command line options -q–phred33-quals -n 2 -e 99999999 -l 25 -I 1 -X 1000 -a -m 200 –p 
4–chunkmbs 512. Next, RSEM v1.27 was run with default parameters on the alignments 
created by Bowtie2 to estimate expression levels. The gene level expression estimates (tau) 
calculated by the RSEm program, were multiplied by 1,000,000 to obtain transcript per 
million (TPM) estimates for each gene, and TPM estimates were transformed to log-space 
by taking log(TPM+1). Genes were considered detected if their transformed expression level 
was equal to or above 1 (in log(TPM+1) scale). A library was filtered out if it had less than 
8,000 genes detected. Based on this criterion, four libraries were filtered out and excluded 
from the downstream analysis. To test the specificity of the dissected brain regions, we 
chose known marker genes in the dentate gyrus region (Igfbp5, Tdo2 and Dsp) and in the 
CA1 region (Nov) and additional shared neuronal markers (Gria1 and Camk2a), and tested 
their relative expression levels (in log(TPM+1) units) within the DG samples and the CA1 
samples in control animals (Supplementary Fig. 8). To find differentially expressed genes 
between control animals and Mecp2 sgRNA expressing animals, Student’s t-test (Matlab 
V2013b) with correction for multiple hypothesis testing (Benjamini-Hochberg FDR 
procedure, q < 0.01) was performed. The t-test was run only on the highly expressed genes, 
which were defined to have mean expression level above 0.9 quantile (~6 log(TPM+1)) 
across all chosen samples. The expression levels (in log(TPM+1) units) of the differentially 
expressed genes across samples were clustered using hierarchical clustering (Matlab 
V2013b).
Immunofluorescent staining
For immunofluorescent staining of primary neurons, cells were fixed 7 d after viral delivery 
with 4% paraformaldehyde (PFA) for 20 min at room temperature (RT). After washing three 
times with PBS, cells were blocked with 5% normal goat serum (NGS) (Life Technologies), 
5% donkey serum (DS) (Sigma) and 0.1% Triton X-100 (Sigma) in PBS for 30 min at RT. 
Cells were incubated with primary antibodies in 2.5% NGS, 2.5% DS and 0.1% Triton 
X-100 for 1 h at RT or overnight at 4 °C. After washing three times with PBST, cells were 
incubated with secondary antibodies for 1 h at RT. Finally, coverslips were mounted using 
VECTASHIELD HardSet Mounting Medium with DAPI (Vector Laboratories) and imaged 
using Zeiss AxioCam A×10 microscope and an Axiocam MRm camera. Images were 
processed using the Zen 2012 software (Zeiss). Quantifications were performed by using 
ImageJ software 1.48 h and Neuron detector plugin.
Mice were euthanized 4 weeks after viral delivery by a lethal dose of ketamine/xylazine and 
transcardially perfused with PBS followed by 4% PFA. Fixed tissue was sectioned using 
vibratome (Leica, VT1000S). Next, 30 μm sections were boiled for 2 min in sodium citrate 
buffer (10 mM tri-sodium citrate dehydrate, 0.05% Tween-20, pH 6.0) and cooled down at 
RT for 20 min. Sections were blocked with 4% normal goat serum (NGS) in TBST (137 
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mM NaCl, 20 mM Tris pH 7.6, 0.2% Tween-20) for 1 h. Sections were incubated with 
primary antibodies diluted in TBST with 4% NGS overnight at 4 °C. After three washes in 
TBST, samples were incubated with secondary antibodies. After washing with TBST three 
times, sections were mounted using VECTASHIELD HardSet Mounting Medium with 
DAPI and visualized with confocal microscope (Zeiss LSM 710, Zen 2012 Software).
Following primary antibodies were used: rabbit anti-MeCP2 (07-013, Millipore, 1:200); 
mouse anti-NeuN (A60, Millipore, 1:50-1:400); chicken anti-GFAP (ab4674, Abcam, 
1:400); mouse anti-Map2 (HM-2, Sigma, 1:500); chicken anti-GFP (1020, Aves labs, 
1:200-1:400); rabbit anti-HA (C29F4, Cell Signaling, 1:100). Secondary antibodies: Alexa 
Fluor 488, 568 or 633 (Life Technologies, 1:500-1:1,000).
Quantification of LIVE/DEAD assay
Control and transduced primary neurons were stained using the LIVE/DEAD assay (Life 
Technologies) according to the manufacturer’s instruction. To avoid interference with the 
GFP signal from GFP-KASH expression, cells were stained for DEAD (ethidium 
homodimer) and DAPI (all cells) only. Stained cells were imaged using fluorescence 
microscopy and DEAD, GFP- and DAPI-positive cells were counted by using ImageJ 1.48h 
software and Neuron detector plug-in.
Western blot analysis
Transduced primary cortical neurons (24-well, 7 d after viral delivery) or transduced tissue 
samples (4 weeks after viral delivery) were lysed in 50 μl of ice-cold RIPA buffer (Cell 
Signaling) containing 0.1% SDS and proteases inhibitors (Roche, Sigma). Cell lysates were 
sonicated for 5 min in a Bioruptor sonicater (Diagenode) and protein concentration was 
determined using the BCA Protein Assay Kit (Pierce Biotechnology, Inc.). Protein lysates 
were dissolved in SDS-PAGE sample buffer, separated under reducing conditions on 4–15% 
Tris-HCl gels (Bio-Rad) and analyzed by western blotting using primary antibodies: rabbit 
anti-Dnmt3a (H-295, Santa Cruz, 1:500), mouse anti-Dnmt1 (60B1220.1, Novus 
Biologicals, 1:800), rabbit anti-MeCP2 (07-013, Millipore, 1:400), mouse anti-HA (6E2, 
Cell Signaling, 1:400) rabbit anti-Tubulin (AA2, Sigma, 1:10,000) followed by secondary 
anti-mouse and anti-rabbit HRP antibodies (Sigma-Aldrich, 1:10,000). GAPDH was directly 
visualized with rabbit HRP coupled anti-GAPDH antibody (14C10, Cell Signaling, 
1:10,000). Tubulin or GAPDH served as loading control. Blots were imaged with ChemiDoc 
MP system with ImageLab 4.1 software (Bio-Rad), and quantified using ImageJ software 
1.48 h.
Fear conditioning
12-week-old C57BL/6N male mice were stereotactically injected with SpCas9 and Mecp2 or 
DNMT targeting sgRNA vectors into the dorsal or dorsal+ventral DG regions, respectively. 
Animals were habituated to the experimenter and the behavior room for 7 d. SpCas9/lacZ 
gRNA-injected littermates served as controls. At day 1, mouse cages were placed into an 
isolated anteroom to prevent mice from hearing auditory cues before and after testing. 
Individual mice were placed into the fear conditioning chamber (Med Associates Inc.) and a 
12 min habituation period was performed. After habituation the mice were placed back to 
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their home cages. The next day (training day), individual mice were placed into the chamber 
and were allowed to habituate for 4 min. After another 20 s (pre-tone) interval, the tone 
(auditory cue) at a level of 85 dB, 2.8 kHz was presented for 20 s followed by 18 s delay 
interval before the foot-shock was presented (0.5 mA, 2 s). After the foot-shock, 40 s 
interval (post-tone/shock) preceded a next identical trial starting with the 20 s pretone 
period. The training trial was repeated six times before the mice were placed back to their 
home cages. At day 3 (testing day), mice were first placed in the conditioning (training) 
context chamber for 3 min. Next, mice were placed in an altered context-conditioning 
chamber (flat floor versus grid, tetrameric versus heptameric chamber, vanillin scent), and 
the testing trial was repeated. Freezing behavior was recorded and analysis was performed 
blind off-line manually and confirmed with Noldus EthoVision XT software (Noldus 
Information Technology).
Open field, novel object recognition and elevated plus maze test
During the open field test, animals were placed in the square arena with opaque walls (40 × 
40 cm, Stoelting) for 10 min while their behavior was recorded. The total distance moved, 
velocity and time spent in the center of arena were scored.
For the novel object recognition test animals were familiarized with the arena (40 × 40cm, 
Stoelting) for 10 min, 24 h before the experiment. During training phase, 2 identical objects 
(black spheres) were placed in the corners of the arena. Animals were positioned in the 
arena facing opposite wall to the objects and left free to explore for 5 min while their 
behavior was scored and recorded. After the training phase animals were returned to home 
cages. After 2 h of delay phase, object recognition test was performed. Animals were placed 
in the arena where one of the familiar objects was swapped with a novel one (white cube). 
Location of the novel object was alternated between animals. Animals were scored and 
recorded for 3 min. Based on the interaction time with objects a discrimination ratio 
(preference for novel object) was calculated: total novel object interaction time/total 
interactions time with both objects.
For the elevated plus maze test mice were placed at the junction of the open and closed arms 
of the maze (Stoelting), facing the open arm opposite to the experimenter and left to explore 
the maze for 5 min. During that time animal was tracked and recorded. The total distance 
traveled in the open arms and time spent in open arms were measured automatically with 
Ethovision software (Noldus).
Next-generation sequencing (NGS) analysis and indel detection
To find potential off-targets for the DNMT family genes, the “CRISPR Design Tool” (http://
crispr.mit.edu/) was used. Targeted cell nuclei from dentate gyrus were FACS sorted 10 
weeks after viral delivery and genomic DNA was purified as described above. For each gene 
of interest, the genomic region flanking the CRISPR target site was amplified by a fusion 
PCR method to attach the Illumina P5 adaptors as well as unique sample-specific barcodes 
to the target amplicons (for on- and off-target primers see Supplementary Table 3)26. 
Barcoded and purified DNA samples were quantified by Qubit 2.0 Fluorometer (Life 
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Technologies) and pooled in an equimolar ratio. Sequencing libraries were then sequenced 
with the Illumina MiSeq Personal Sequencer (Life Technologies), with 300 bp reads length.
The MiSeq reads for pooled nuclei were analyzed as described previously26. Briefly, reads 
were filtered by Phred quality (Q score) and aligned using a Smith-Waterman algorithm to 
the genomic region 50 nucleotides upstream and downstream of the target site. Indels were 
estimated in the aligned region from 5 nucleotides upstream to 5 nucleotides downstream of 
the target site (a total of 30 bp). Negative controls for each sample were used to estimate the 
inclusion or exclusion of indels as putative cutting events. We computed a maximum-
likelihood estimator (MLE) for the fraction of reads having target-regions with true-indels, 
using the per-target-region-per-read error rate from the data of the negative control sample. 
The MLE scores for each off-target are listed in Supplementary Table 1.
The MiSeq reads for single nuclei was analyzed slightly differently. First, samples with 
count of reads less than 100 were removed from analysis. Sequencing reads were aligned 
separately to primer sequence and 10 bp genomic sequence taken from 3′ downstream of the 
primer sequence using a Smith-Waterman algorithm. Reads were filtered out if there was 
any indel found within the alignment. Next, reads were trimmed from the 10 bp genomic 
sequence and aligned to the 23 bp guide sequence (target sequence + PAM sequencing). An 
alignment is considered as having an indel if an indel is found within ±6 bp around the 
expected Cas9 cut site. Indel pattern distribution was obtained by counting alignments 
containing different indel sequences separately. In order to model sequencing error, reads 
were aligned to another 23 bp genomic sequencing on 3′ downstream of the 10 bp genomic 
sequencing used in previous alignment, and distribution of alignments containing indels, 
denoted as indel types, was quantified. Sequencing reads containing indel was modeled as 
Bernoulli random variable and the parameter was fitted with a gamma distribution. For the 
following analysis, we chose the threshold for sequencing error rate at the false discovery 
rate of 2%. Sequencing reads from each single nuclei were filtered in order to remove 
possible doublet contaminations, whose ratio of second dominant indel type to the first 
dominant indel type and ratio of the third dominant indel type to the second dominant indel 
type both were found higher than the threshold for sequencing error. Next each single nuclei 
was classified as (i) wild-type, if the fraction of reads containing indels was lower than the 
sequencing error threshold, (ii) double allelic modified, if the fraction of reads containing no 
indel was lower than the sequencing error threshold, (iii) single allelic modified, if it did not 
fit to the two scenarios.
Statistical analysis
If not stated otherwise data were analyzed with GraphPad Prism 6.0 software (Graphpad 
Software). Groups were compared using an unpaired, two sided t-test. Normal distribution 
was assumed. Data are shown as mean with s.e.m.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Targeting of Mecp2 locus in the adult mouse brain with SpCas9. (a) AAV-SpCas9 and 
AAV-SpGuide expression vectors. The sgRNA vector contains encoding sequence of the 
GFP-KASH fusion protein for identification of transduced neurons. (b) Strategy for cell 
nuclei purification of CRISPR-Cas9 targeted cells from the mouse brain. Scale bars: 3 mm 
(brain), 50 μm (sorted nuclei). (c) Graphical representation of the mouse Mecp2 locus 
showing SpCas9 target location; targeted genomic locus indicated in blue. PAM sequence 
marked in magenta. Representative mutation patterns detected by sequencing of Mecp2 
locus shown below: top, wild-type sequence; red dashes, deleted bases; red bases: insertion 
or mutations (indel); red arrowhead indicates CRISPR-Cas9 cutting site. (d) Indel frequency 
in SpCas9 targeted Mecp2 locus (240 sorted nuclei from dissected hippocampi; n = 4 male 
mice, 2 weeks after AAV injection). Fraction of missense and nonsense mutations is shown. 
Distribution of indel length in single sorted nuclei is shown on the bar graph below. (e) 
Immunostaining of dorsal DG region 2 weeks after CRISPR-Cas9 targeting of Mecp2 locus 
in male mice. Scale bar, 150 μm. (f) Quantification of MeCP2 positive cells population 
within all detected cells (DAPI staining) in DG compare to control (t-test, ****P < 0.0001, n 
= 290 and 249 cells from 2 male mice, respectively; error bars: s.e.m.). (g) Western blot 
analysis of MeCP2 protein expression 2 weeks after AAV injection and quantification of 
MeCP2 protein levels in dorsal DG (t-test, **P < 0.01, n = 4 tissue punches from male mice, 
error bars: s.e.m.). (h) Contextual learning deficits after targeting Mecp2 using SpCas9 in 
the dorsal DG region of hippocampus, tested in training and altered context (t-test, *P < 
0.05, n = 7 male mice, 3 weeks after AAV delivery; error bars: s.e.m.). ITR, inverted 
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terminal repeat; HA, hemagglutinin tag; NLS, nuclear localization signal; spA, synthetic 
polyadenylation signal; U6, Pol III promoter; sgRNA, single guide RNA; hSyn, human 
synapsin 1 promoter; GFP, green fluorescent protein; KASH, Klarsicht, ANC1, Syne 
Homology nuclear transmembrane domain; bGH pA, bovine growth hormone 
polyadenylation signal; WPRE, Woodchuck Hepatitis virus posttranscriptional regulatory 
element.
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Figure 2. 
Analysis of gene expression in SpCas9-mediated MeCP2 knockdown neurons. Hierarchical 
clustering of differentially expressed genes (t-test, 0.01 FDR, n = 19 populations of sorted 
nuclei from 8 male mice, 2 weeks after AAV delivery) detected by RNA-seq. Relative 
log(TPM+1) expression levels of genes are normalized for each row and displayed in red-
blue color scale. Each column represents a population of targeted 100 neuronal nuclei FACS 
sorted from the isolated, dentate gyrus population of cells, either from Mecp2 or control 
(lacZ) sgRNA transduced animals, as indicated. TPM, transcripts per million.
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Figure 3. 
Changes in response properties of visual cortex neurons after SpCas9-mediated MeCP2 
knockdown. (a) Immunostaining of cortex (V1), 2 weeks after CRISPR-Cas9 targeting of 
Mecp2 locus in male mice. Virus injected site, and uninjected control contralateral side are 
shown. Scale bar, 50 μm. (b) Experimental configuration. To assess visual responses of 
neurons in primary visual cortex (V1), we presented visual stimuli (oriented gratings) on an 
LCD monitor placed in front of anesthetized mice. Two weeks before experiment, mixture 
of SpCas9 with either Mecp2 sgRNA or control sgRNA (lacZ) was stereotactically injected 
in V1. GFP-KASH+ neurons and GFP-KASH− neurons were recorded. Example of recorded 
GFP-KASH+ neuron is shown. Scale bar, 20 μm. (c) In vivo targeted cell-attached recording 
configuration from V1 layer 2/3 excitatory neurons that receive visual drive (ipsilateral and 
contralateral input). Genome modified GFP-KASH+/MeCP2− cells are shown in green, 
unmodified GFP-KASH−/MeCP2+ cells in gray. Recording pipette is indicated. Normalized 
mean spike shape (green) shows regular spiking excitatory neurons. Scale bar, 1 ms. (d, e) 
Orientation-selective responses of typical GFP-KASH+ neurons expressing Mecp2 sgRNA 
(d) or lacZ sgRNA (e). (f, g) Orientation selectivity index (f) and peak responses (g) 
(spikes/s) measured from GFP-KASH+ cells expressing Mecp2 and control sgRNA, 
respectively, and comparison with GFP-KASH− cells (*P < 0.05, t-test; numbers on bars 
indicate numbers of recorded cells; n = 2–3 animals per group; error bars: s.e.m.).
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Figure 4. 
Simultaneous, multiplex gene editing in the mouse brain. (a) Schematic illustration of AAV 
vectors for multiplex genome targeting. (b) Graphical representation of targeted DNMT 
mouse loci. Targeted genomic loci are indicated in blue. PAM sequences are marked in 
magenta. (c) Next-generation sequencing-based analysis of indel frequency formation within 
Dnmt1, Dnmt3a and Dnmt3b loci analyzed in single neuronal nuclei. Fractions of mono- and 
biallelic modification are shown (n = 79 cells). (d) NGS analysis of DNMTs loci 
modification in single cells, showing co-occurrence of modification in multiple loci. (e) 
Western blot analysis for Dnmt3a and Dnmt1 proteins after in vivo delivery of CRISPR-
Cas9 system targeting DNMT family genes in neurons (top). Western blot quantification of 
Dnmt3a and Dnmt1 protein levels in DG after in vivo CRISPR-Cas9 targeting (bottom; t-
test, **P < 0.001, *P < 0.05, Dnmt3a: n = 7; Dnmt1: n = 5 from 5 animals; error bars: 
s.e.m.). (f) Contextual learning deficits, 8 weeks after targeting of DNMT genes using 
SpCas9 in the DG region of hippocampus, tested in training and altered context (t-test, ***P 
< 0.001, n = 18 animals; error bars: s.e.m.).
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